DaVita Healthcare Partners | DVA - Sales Revenues

Stock Price
110.75
Daily Change
1.41 1.29%
Monthly
-2.80%
Yearly
-37.45%
Q1 Forecast
105.97

DaVita Healthcare Partners reported $3.42B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Acadia Healthcare USD 851.6M 17.6M Sep/2025
Addus HomeCare USD 362.3M 12.9M Sep/2025
Brookdale Senior Living USD 813.16M 34.92M Sep/2025
Cardinal Health USD 64B 3.8B Sep/2025
Centene USD 49.69B 950M Sep/2025
Chemed USD 624.9M 6.1M Sep/2025
Cigna USD 69.7B 2.5B Sep/2025
Corvel USD 240M 5.29M Sep/2025
CVS Health USD 102.9B 3.99B Sep/2025
DaVita Healthcare Partners USD 3.42B 40M Sep/2025
Elevance Health USD 49.3B 790M Dec/2025
Encompass Health USD 1.48B 20M Sep/2025
Ensign USD 1.3B 70M Sep/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 4.89B 100M Sep/2025
HCA USD 19.51B 350M Dec/2025
Humana USD 32.65B 260M Sep/2025
Laboratory Of America USD 3.56B 30M Sep/2025
McKesson USD 103.15B 5.32B Sep/2025
Molina Healthcare USD 11.48B 50M Sep/2025
Option Care Health USD 1.44B 20M Sep/2025
Quest Diagnostics USD 2.82B 60M Sep/2025
RadNet USD 522.87M 24.64M Sep/2025
Select Medical USD 1.36B 80M Sep/2025
Tenet Healthcare USD 5.29B 20M Sep/2025
UnitedHealth USD 113.2B 0 Dec/2025
Universal Health Services USD 4.5B 220M Sep/2025